Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
| |||
| December 30,
|
| December 31,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 227,504 |
| $ 499,915 |
Short-term investments | 211,720 |
| 692,024 |
Accounts receivable, net | 29,295 |
| 71,437 |
Inventories | 194,295 |
| 100,417 |
Prepaid expenses and other current assets | 75,117 |
| 97,570 |
Total current assets | 737,931 |
| 1,461,363 |
Property and equipment, net | 145,890 |
| 152,016 |
Goodwill | 376,389 |
| 376,389 |
Other intangible assets, net | 59,533 |
| 84,907 |
Other assets, net | 123,313 |
| 94,753 |
Total assets | $1,443,056 |
| $2,169,428 |
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable | $ 57,498 |
| $ 89,860 |
Revolving line of credit | 45,000 |
| -- |
Deferred revenue and returns liability | 2,117 |
| 6,780 |
Other current liabilities | 58,955 |
| 89,136 |
Total current liabilities | 163,570 |
| 185,776 |
Convertible debt, net | -- |
| 529,573 |
Other non-current liabilities | 70,804 |
| 49,071 |
Total liabilities | 234,374 |
| 764,420 |
Commitments and contingencies |
|
|
|
Stockholders' equity: |
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- |
| -- |
Common stock – $0.0001 par value; 250,000 shares authorized; 31,897 and 31,994 shares issued and outstanding at December 30, 2023 and December 31, 2022, respectively | 3 |
| 3 |
Additional paid-in capital | 16,973 |
| -- |
Retained earnings | 1,192,731 |
| 1,415,693 |
Accumulated other comprehensive loss | (1,025) |
| (10,688) |
Total stockholders' equity | 1,208,682 |
| 1,405,008 |
Total liabilities and stockholders' equity | $1,443,056 |
| $2,169,428 |